Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist

被引:34
作者
Pasternak, Alexander [1 ]
Goble, Stephen D. [1 ]
Struthers, Mary [1 ]
Vicario, Pasquale P. [1 ]
Ayala, Julia M. [1 ]
Di Salvo, Jerry [1 ]
Kilburn, Ruth [1 ]
Wisniewski, Thomas [1 ]
DeMartino, Julie A. [1 ]
Mills, Sander G. [1 ]
Yang, Lihu [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
关键词
CCR2; CCR5; chemokine; dual antagonist; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; RECEPTOR; DISEASE; MICE;
D O I
10.1021/ml900009d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This report describes the discovery of a potent, orally bioavailable CC chemokine receptor 2 (CCR2) antagonist which, while optimized for CCR2 potency, also had potent CC chemokine receptor 5 (CCR5) activity
引用
收藏
页码:14 / 18
页数:5
相关论文
共 31 条
[1]   Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 [J].
Abbadie, C ;
Lindia, JA ;
Cumiskey, AM ;
Peterson, LB ;
Mudgett, JS ;
Bayne, EK ;
DeMartino, JA ;
MacIntyre, DE ;
Forrest, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7947-7952
[2]  
Beaulieu A, 2006, ANN RHEUM DIS, V65, P175
[3]   3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2 [J].
Butora, Gabor ;
Jiao, Richard ;
Parsons, William H. ;
Vicario, Pasquale P. ;
Jin, Hong ;
Ayala, Julia M. ;
Cascieri, Margaret A. ;
Yang, Lihu .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) :3636-3641
[4]  
Cavero I, 2000, Expert Opin Pharmacother, V1, P947, DOI 10.1517/14656566.1.5.947
[5]   MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS [J].
CHARO, IF ;
MYERS, SJ ;
HERMAN, A ;
FRANCI, C ;
CONNOLLY, AJ ;
COUGHLIN, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2752-2756
[6]  
Davidson M, 2007, CIRCULATION, V116, P171
[7]  
Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35
[8]   Therapy for chronic obstructive pulmonary disease in the 21st century [J].
Donnelly, LE ;
Rogers, DF .
DRUGS, 2003, 63 (19) :1973-1998
[9]   The CCR2 receptor as a therapeutic target [J].
Feria, M ;
Díaz-González, F .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (01) :49-57
[10]   An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model [J].
Gong, JH ;
Ratkay, LG ;
Waterfield, JD ;
ClarkLewis, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :131-137